Price target
461.75RINR+73.05+18.79%
The 4 analysts offering 1 year price forecasts for KOLTE PATIL DEV. LTD. have a max estimate of 480.00 and a min estimate of 440.00.
Analyst rating
Based on 4 analysts giving stock ratings to KOLTE PATIL DEV. LTD. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
4
Buy
0
Hold
0
Sell
0
Strong sell
0
EPS
Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−14.00
−7.00
0.00
7.00
14.00
Reported
Estimate
Currency: INR
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
6.00
−3.30
−8.30
−3.60
0.80
1.25
3.30
—
—
Estimate
2.60
2.20
6.60
13.80
3.00
3.00
4.20
9.90
—
Surprise
+130.77%
−250.00%
−225.76%
−126.09%
−73.33%
−58.33%
−21.43%
—
—
Revenue
Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
2.00 B
4.00 B
6.00 B
8.00 B
Reported
Estimate
Currency: INR
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
5.71 B
1.98 B
758.00 M
5.26 B
3.41 B
3.08 B
3.50 B
—
—
Estimate
2.72 B
4.04 B
3.73 B
6.17 B
3.57 B
3.91 B
4.10 B
7.99 B
—
Surprise
+109.85%
−50.88%
−79.69%
−14.69%
−4.43%
−21.06%
−14.71%
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
KOLTEPATIL EPS for the last quarter is 3.30 INR despite the estimation of 4.20 INR. In the next quarter EPS is expected to reach 9.90 INR. Track more of KOLTE PATIL DEV. LTD. financials and stay on top of what is up with the company.
In the next quarter KOLTE PATIL DEV. LTD. revenue is expected to reach 7.99 B INR. Check out KOLTE PATIL DEV. LTD. revenue and earnings and make informed decisions.
According to analysts, KOLTEPATIL price target is 461.75 INR with a max estimate of 480.00 INR and a min estimate of 440.00 INR. Check if this forecast comes true in a year, meanwhile watch KOLTE PATIL DEV. LTD. stock price chart and keep track of the current situation with KOLTEPATIL news and stock market news.